Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, has raised $105 million in Series B financing. Lightchain Capital and NT Investments led the round.
Source: Press Release
Geneoscopy fetches $105m Series B
Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, has raised $105 million in Series B financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: